Earnings Ahead

STAA - STAAR Surgical Company

50.8 -0.29 -0.57

STAAR Surgical Company

STAAR Surgical Company

About

Profile


Headquarters

Monrovia, California, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

STAA



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • STAAR Surgical GAAP EPS of $0.16 beats by $0.13, revenue of $76.3M beats by $0.51M
  • STAAR Surgical Q4 2023 Earnings Preview
  • STAAR Surgical collaborates with SharpeVision in the U.S.
  • STAAR Surgical forecasts 2024 net sales between $335M - $340M
  • It's JPM time! Which medtechs are expected to issue updates this week?
  • Staar Surgical projects 15%-20% sales growth in 2024-2026
  • STAAR Surgical Non-GAAP EPS of $0.31 beats by $0.13, revenue of $80.3M in-line
  • STAAR Surgical Q3 2023 Earnings Preview
  • Staar Surgical sees FY26 sales $500M-$550M, operating margin of 12%-16%
  • STAAR Surgical gains after shareholder buys additional stake worth $7.87M
  • Dolby Laboratories set to join S&P midcap 400; Staar Surgical to join S&P smallcap 600
  • Canaccord cuts STAAR to hold, citing US adoption challenges for EVO lenses
  • STAAR Surgical misses Q2 top and bottom line estimates; updates FY23 outlook
  • STAAR Surgical Q2 2023 Earnings Preview
  • STAAR Surgical downgraded to market perform by William Blair
  • STAAR Surgical GAAP EPS of $0.05 beats by $0.06, revenue of $73.5M beats by $7.28M
  • STAAR Surgical Q1 2023 Earnings Preview
  • STAAR Surgical hires Warren Foust as COO
  • STAAR Surgical gains after reaffirming sales forecast
  • STAAR Surgical falls as 2023 outlook disappoints